| 1 |
Huybrechts Y, Evenepoel P, Haarhaus M, Cavalier E, Dams G, Van Hul W, D'Haese PC, Verhulst A. Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover. Nutrients 2023;15. [PMID: 36771305 DOI: 10.3390/nu15030598] [Reference Citation Analysis]
|
| 2 |
Bellorin-Font E, Rojas E, Martin KJ. Bone Disease in Chronic Kidney Disease and Kidney Transplant. Nutrients 2022;15. [PMID: 36615824 DOI: 10.3390/nu15010167] [Reference Citation Analysis]
|
| 3 |
Kushchayeva Y, Pestun I, Kushchayev S, Radzikhovska N, Lewiecki EM. Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing. J Clin Med 2022;11. [PMID: 36556093 DOI: 10.3390/jcm11247477] [Reference Citation Analysis]
|
| 4 |
Karlovich NV, Spiridonova OS, Mokhort TV, Vasilyeva NA, Snapkov VS, Serdyuchenko NS. Biochemical markers of bone metabolism in the diagnosis of mineral and bone disorders associated with chronic kidney disease. Vescì Nac akad navuk Belarusì, Ser med navuk 2022;19:263-277. [DOI: 10.29235/1814-6023-2022-19-3-263-277] [Reference Citation Analysis]
|
| 5 |
William Whitehouse R, Ahmad G, Kirwadi A, Matthew Howard J. Imaging of Chronic Kidney Disease-Mineral and Bone Disorder. Radiol Clin North Am 2022;60:547-59. [PMID: 35672088 DOI: 10.1016/j.rcl.2022.02.004] [Reference Citation Analysis]
|
| 6 |
Dalle Carbonare L, Valenti MT, Giannini S, Gallieni M, Stefani F, Ciresa R, Politi C, Fusaro M. Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New Perspectives. J Clin Med 2021;10:4617. [PMID: 34640633 DOI: 10.3390/jcm10194617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Bover J, Arana C, Ureña P, Torres A, Martín-malo A, Fayos L, Coll V, Lloret MJ, Ochoa J, Almadén Y, Guirado L, Rodríguez M. Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease. Nefrología (English Edition) 2021;41:514-28. [DOI: 10.1016/j.nefroe.2021.11.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Bover J, Arana C, Ureña P, Torres A, Martín-Malo A, Fayos L, Coll V, Lloret MJ, Ochoa J, Almadén Y, Guirado L, Rodríguez M. Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease. Nefrologia (Engl Ed) 2021:S0211-6995(21)00070-9. [PMID: 33985858 DOI: 10.1016/j.nefro.2020.12.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Cannata-Andía J, Carrillo-López N, Ferreira A. Bone in CKD, a Fascinating Evolving Topic. Calcif Tissue Int 2021;108:407-9. [PMID: 33822254 DOI: 10.1007/s00223-021-00821-8] [Reference Citation Analysis]
|
